vs
科睿唯安（CLVT）与NATIONAL HEALTHCARE CORP（NHC）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是NATIONAL HEALTHCARE CORP的1.5倍（$585.5M vs $386.5M），NATIONAL HEALTHCARE CORP净利率更高（6.4% vs -6.9%，领先13.3%），NATIONAL HEALTHCARE CORP同比增速更快（4.6% vs -1.4%），科睿唯安自由现金流更多（$78.9M vs $6.4M），过去两年NATIONAL HEALTHCARE CORP的营收复合增速更高（14.0% vs -5.1%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
HCA Healthcare是1968年成立的美国营利性医疗服务运营商，总部位于田纳西州纳什维尔。截至2020年5月，该公司在全美20个州及英国持有并运营186家医院，还有约2400个医疗服务网点，涵盖手术中心、独立急诊室、紧急护理中心及医师诊所，2024年位列美国财富500强第61位。
CLVT vs NHC — 直观对比
营收规模更大
CLVT
是对方的1.5倍
$386.5M
营收增速更快
NHC
高出6.0%
-1.4%
净利率更高
NHC
高出13.3%
-6.9%
自由现金流更多
CLVT
多$72.5M
$6.4M
两年增速更快
NHC
近两年复合增速
-5.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $386.5M |
| 净利润 | $-40.2M | $24.8M |
| 毛利率 | 67.2% | — |
| 营业利润率 | 5.2% | 8.6% |
| 净利率 | -6.9% | 6.4% |
| 营收同比 | -1.4% | 4.6% |
| 净利润同比 | 61.3% | 308.6% |
| 每股收益（稀释后） | $-0.06 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTNHC
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $386.5M | ||
| Q3 25 | $623.1M | $382.7M | ||
| Q2 25 | $621.4M | $374.9M | ||
| Q1 25 | $593.7M | $373.7M | ||
| Q4 24 | $663.0M | $369.4M | ||
| Q3 24 | $622.2M | $340.2M | ||
| Q2 24 | $650.3M | $300.7M |
净利润CLVTNHC
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $24.8M | ||
| Q3 25 | $-28.3M | $39.2M | ||
| Q2 25 | $-72.0M | $23.7M | ||
| Q1 25 | $-103.9M | $32.2M | ||
| Q4 24 | $-191.8M | $6.1M | ||
| Q3 24 | $-65.6M | $42.8M | ||
| Q2 24 | $-304.3M | $26.8M |
毛利率CLVTNHC
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | — | ||
| Q3 24 | 66.2% | — | ||
| Q2 24 | 67.2% | — |
营业利润率CLVTNHC
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | 8.6% | ||
| Q3 25 | 7.1% | 7.9% | ||
| Q2 25 | 1.1% | 9.1% | ||
| Q1 25 | -3.5% | 8.2% | ||
| Q4 24 | -9.4% | 7.8% | ||
| Q3 24 | 3.5% | 6.7% | ||
| Q2 24 | -36.9% | 7.5% |
净利率CLVTNHC
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | 6.4% | ||
| Q3 25 | -4.5% | 10.3% | ||
| Q2 25 | -11.6% | 6.3% | ||
| Q1 25 | -17.5% | 8.6% | ||
| Q4 24 | -28.9% | 1.6% | ||
| Q3 24 | -10.5% | 12.6% | ||
| Q2 24 | -46.8% | 8.9% |
每股收益（稀释后）CLVTNHC
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | $1.58 | ||
| Q3 25 | $-0.04 | $2.50 | ||
| Q2 25 | $-0.11 | $1.52 | ||
| Q1 25 | $-0.15 | $2.07 | ||
| Q4 24 | $-0.27 | $0.38 | ||
| Q3 24 | $-0.09 | $2.73 | ||
| Q2 24 | $-0.46 | $1.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $92.8M |
| 总债务越低越好 | $4.3B | $40.0M |
| 股东权益账面价值 | $4.8B | $1.1B |
| 总资产 | $10.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.89× | 0.04× |
8季度趋势，按日历期对齐
现金及短期投资CLVTNHC
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | $92.8M | ||
| Q3 25 | $318.7M | $130.6M | ||
| Q2 25 | $362.6M | $111.0M | ||
| Q1 25 | $354.0M | $90.4M | ||
| Q4 24 | $295.2M | $76.1M | ||
| Q3 24 | $388.5M | $84.8M | ||
| Q2 24 | $376.4M | $136.2M |
总债务CLVTNHC
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $40.0M | ||
| Q3 25 | $4.4B | $73.1M | ||
| Q2 25 | $4.5B | $110.0M | ||
| Q1 25 | $4.5B | $134.0M | ||
| Q4 24 | $4.5B | $137.0M | ||
| Q3 24 | $4.6B | $147.0M | ||
| Q2 24 | $4.6B | — |
股东权益CLVTNHC
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $1.1B | ||
| Q3 25 | $4.9B | $1.1B | ||
| Q2 25 | $5.0B | $1.0B | ||
| Q1 25 | $5.0B | $1.0B | ||
| Q4 24 | $5.1B | $980.2M | ||
| Q3 24 | $5.5B | $983.5M | ||
| Q2 24 | $5.6B | $945.8M |
总资产CLVTNHC
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $1.5B | ||
| Q3 25 | $11.2B | $1.6B | ||
| Q2 25 | $11.4B | $1.6B | ||
| Q1 25 | $11.5B | $1.5B | ||
| Q4 24 | $11.5B | $1.5B | ||
| Q3 24 | $12.0B | $1.6B | ||
| Q2 24 | $12.1B | $1.3B |
负债/权益比CLVTNHC
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | 0.04× | ||
| Q3 25 | 0.90× | 0.07× | ||
| Q2 25 | 0.90× | 0.11× | ||
| Q1 25 | 0.90× | 0.13× | ||
| Q4 24 | 0.88× | 0.14× | ||
| Q3 24 | 0.84× | 0.15× | ||
| Q2 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $16.8M |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $6.4M |
| 自由现金流率自由现金流/营收 | 13.5% | 1.7% |
| 资本支出强度资本支出/营收 | 9.5% | 2.7% |
| 现金转化率经营现金流/净利润 | — | 0.68× |
| 过去12个月自由现金流最近4个季度 | $333.9M | $148.6M |
8季度趋势，按日历期对齐
经营现金流CLVTNHC
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $16.8M | ||
| Q3 25 | $181.1M | $66.2M | ||
| Q2 25 | $116.3M | $62.8M | ||
| Q1 25 | $171.2M | $39.3M | ||
| Q4 24 | $141.3M | $12.8M | ||
| Q3 24 | $202.9M | $34.2M | ||
| Q2 24 | $126.2M | $50.7M |
自由现金流CLVTNHC
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $6.4M | ||
| Q3 25 | $115.5M | $56.5M | ||
| Q2 25 | $50.3M | $52.6M | ||
| Q1 25 | $110.3M | $33.1M | ||
| Q4 24 | $59.1M | $4.6M | ||
| Q3 24 | $126.3M | $28.6M | ||
| Q2 24 | $60.3M | $42.8M |
自由现金流率CLVTNHC
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | 1.7% | ||
| Q3 25 | 18.5% | 14.8% | ||
| Q2 25 | 8.1% | 14.0% | ||
| Q1 25 | 18.6% | 8.9% | ||
| Q4 24 | 8.9% | 1.3% | ||
| Q3 24 | 20.3% | 8.4% | ||
| Q2 24 | 9.3% | 14.2% |
资本支出强度CLVTNHC
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 2.7% | ||
| Q3 25 | 10.5% | 2.5% | ||
| Q2 25 | 10.6% | 2.7% | ||
| Q1 25 | 10.3% | 1.6% | ||
| Q4 24 | 12.4% | 2.2% | ||
| Q3 24 | 12.3% | 1.7% | ||
| Q2 24 | 10.1% | 2.6% |
现金转化率CLVTNHC
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 0.68× | ||
| Q3 25 | — | 1.69× | ||
| Q2 25 | — | 2.65× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | 2.10× | ||
| Q3 24 | — | 0.80× | ||
| Q2 24 | — | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
NHC
| Inpatient Services Segment | $333.7M | 86% |
| Homecare Services Segment | $40.0M | 10% |
| Other | $11.2M | 3% |
| National | $1.6M | 0% |
